Related Experiment Video
Updated: May 24, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53
Hao Ding1, Jiang-jing Xu, Yuan Huang
1Department of Gastroenterology, Second Affiliated Hospital, Nanchang University, Nanchang, PR China.
Objectives:
We investigated the effects of xeroderma pigmentosum D (XPD) on the growth of hepatoma cells and the expressions of P21, Bax, Bcl-2 and Hepatitis B virus X protein (HBx). In addition, we examined whether XPD affected the aforementioned genes via the P53 pathway.
Methods:
Human hepatoma cells (HepG2.2.15) were transfected with XPD expression vector, followed by incubation with Pifithrin-α (P53 inhibitor). By using RT-PCR and Western blotting, the expression levels of XPD, P53, phospho-P53 (ser-15), P21, Bax, Bcl-2 and HBx were detected. The cell cycle and the apoptosis rate were examined with flow cytometry, and the cell viability was detected by MTT.
Results:
Over-expression of XPD up-regulated the expressions of P53, phospho-P53 (ser-15), P21 and Bax but down-regulated the expressions of Bcl-2 and HBx. XPD inhibited the viability of HepG2.2.15 and exacerbated the apoptosis. However, the inhibition of P53 by Pifithrin-α abolished the above-mentioned effects of XPD.
Conclusion:
XPD could suppress growth of hepatoma cells, up-regulate the expressions of P21 and Bax, and down-regulate the expressions of Bcl-2 and HBx through the P53 pathway. There may be mutual influences among XPD, P53 and HBx that co-regulate hepatocarcinogenesis.
Insights
Xeroderma pigmentosum D (XPD) suppresses hepatoma cell growth by regulating P53 pathway genes, including P21 and Bax. XPD
Area of Science:
- Hepatocellular carcinoma research
- Molecular oncology
- DNA repair mechanisms
Background:
- Hepatoma cell growth is complex and influenced by various proteins.
- The role of Xeroderma pigmentosum D (XPD) in hepatocarcinogenesis is not fully understood.
- The P53 pathway is a critical regulator of cell cycle and apoptosis in cancer.
Purpose of the Study:
- To investigate the effect of XPD on hepatoma cell growth.
- To analyze the impact of XPD on P21, Bax, Bcl-2, and Hepatitis B virus X protein (HBx) expression.
- To determine if XPD influences these genes via the P53 pathway.
Main Methods:
- Transfection of human hepatoma cells (HepG2.2.15) with XPD expression vector.
- Inhibition of the P53 pathway using Pifithrin-α.
- Analysis of gene expression (RT-PCR, Western blotting) and cell behavior (flow cytometry, MTT assay).
Main Results:
- XPD overexpression increased P53, phospho-P53, P21, and Bax levels, while decreasing Bcl-2 and HBx.
- XPD inhibited hepatoma cell viability and promoted apoptosis.
- Inhibition of P53 abolished the effects of XPD on cell growth and apoptosis.
Conclusions:
- XPD suppresses hepatoma cell growth by modulating P53 pathway targets P21, Bax, Bcl-2, and HBx.
- XPD's influence on hepatocarcinogenesis may involve intricate interactions with P53 and HBx.
- Targeting XPD could be a potential therapeutic strategy for hepatocellular carcinoma.
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
Negative Regulator Molecules

